About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Multiple Sclerosis Drugs Market is Forecasted to grow at a CAGR of 3.7% by 2031
Multiple Sclerosis Drugs Market
Multiple Sclerosis Drugs Market

Multiple Sclerosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Others), By Route of Administration (Oral, Injectables, Infusions), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores), By Disease Type (Relapsing-remitting MS (RRMS), Primary-progressive MS (PPMS), Secondary-progressive MS (SPMS), Progressive-relapsing MS (PRMS)) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH1498DR
Last Updated : Nov 29, 2022
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Multiple Sclerosis Drugs Market, By Drug Class (2021-2031)
    1. Immunomodulators
    2. Immunosuppressants
    3. Interferons
    4. Others
  2. Multiple Sclerosis Drugs Market, By Route of Administration (2021-2031)
    1. Oral
    2. Injectables
      1. Intramuscular
      2. Subcutaneous
      3. Intravenous
    3. Infusions
  3. Multiple Sclerosis Drugs Market, By Distribution Channel (2021-2031)
    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Online Stores
  4. Multiple Sclerosis Drugs Market, By Disease Type (2021-2031)
    1. Relapsing-remitting MS (RRMS)
    2. Primary-progressive MS (PPMS)
    3. Secondary-progressive MS (SPMS)
    4. Progressive-relapsing MS (PRMS)
    1. North America
      1. North America Multiple Sclerosis Drugs Market, By Drug Class
        1. Immunomodulators
          1. Immunosuppressants
            1. Interferons
              1. Others
              2. North America Multiple Sclerosis Drugs Market, By Route of Administration
                1. Oral
                  1. Injectables
                    1. Intramuscular
                      1. Subcutaneous
                        1. Intravenous
                        2. Infusions
                        3. North America Multiple Sclerosis Drugs Market, By Distribution Channel
                          1. Hospital Pharmacy
                            1. Retail Pharmacy
                              1. Online Stores
                              2. North America Multiple Sclerosis Drugs Market, By Disease Type
                                1. Relapsing-remitting MS (RRMS)
                                  1. Primary-progressive MS (PPMS)
                                    1. Secondary-progressive MS (SPMS)
                                      1. Progressive-relapsing MS (PRMS)
                                      2. U.S.
                                        1. U.S. Multiple Sclerosis Drugs Market, By Drug Class
                                          1. Immunomodulators
                                            1. Immunosuppressants
                                              1. Interferons
                                                1. Others
                                                2. U.S. Multiple Sclerosis Drugs Market, By Route of Administration
                                                  1. Oral
                                                    1. Injectables
                                                      1. Intramuscular
                                                        1. Subcutaneous
                                                          1. Intravenous
                                                          2. Infusions
                                                          3. U.S. Multiple Sclerosis Drugs Market, By Distribution Channel
                                                            1. Hospital Pharmacy
                                                              1. Retail Pharmacy
                                                                1. Online Stores
                                                                2. U.S. Multiple Sclerosis Drugs Market, By Disease Type
                                                                  1. Relapsing-remitting MS (RRMS)
                                                                    1. Primary-progressive MS (PPMS)
                                                                      1. Secondary-progressive MS (SPMS)
                                                                        1. Progressive-relapsing MS (PRMS)
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Multiple Sclerosis Drugs Market, By Drug Class
                                                                        1. Immunomodulators
                                                                          1. Immunosuppressants
                                                                            1. Interferons
                                                                              1. Others
                                                                              2. Europe Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                1. Oral
                                                                                  1. Injectables
                                                                                    1. Intramuscular
                                                                                      1. Subcutaneous
                                                                                        1. Intravenous
                                                                                        2. Infusions
                                                                                        3. Europe Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                          1. Hospital Pharmacy
                                                                                            1. Retail Pharmacy
                                                                                              1. Online Stores
                                                                                              2. Europe Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                      2. U.K.
                                                                                                        1. U.K. Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                          1. Immunomodulators
                                                                                                            1. Immunosuppressants
                                                                                                              1. Interferons
                                                                                                                1. Others
                                                                                                                2. U.K. Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                  1. Oral
                                                                                                                    1. Injectables
                                                                                                                      1. Intramuscular
                                                                                                                        1. Subcutaneous
                                                                                                                          1. Intravenous
                                                                                                                          2. Infusions
                                                                                                                          3. U.K. Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                            1. Hospital Pharmacy
                                                                                                                              1. Retail Pharmacy
                                                                                                                                1. Online Stores
                                                                                                                                2. U.K. Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                        1. Immunomodulators
                                                                                                                                          1. Immunosuppressants
                                                                                                                                            1. Interferons
                                                                                                                                              1. Others
                                                                                                                                              2. APAC Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                1. Oral
                                                                                                                                                  1. Injectables
                                                                                                                                                    1. Intramuscular
                                                                                                                                                      1. Subcutaneous
                                                                                                                                                        1. Intravenous
                                                                                                                                                        2. Infusions
                                                                                                                                                        3. APAC Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                          1. Hospital Pharmacy
                                                                                                                                                            1. Retail Pharmacy
                                                                                                                                                              1. Online Stores
                                                                                                                                                              2. APAC Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                            1. Immunosuppressants
                                                                                                                                                                              1. Interferons
                                                                                                                                                                                1. Others
                                                                                                                                                                                2. China Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                  1. Oral
                                                                                                                                                                                    1. Injectables
                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                        1. Subcutaneous
                                                                                                                                                                                          1. Intravenous
                                                                                                                                                                                          2. Infusions
                                                                                                                                                                                          3. China Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                            1. Hospital Pharmacy
                                                                                                                                                                                              1. Retail Pharmacy
                                                                                                                                                                                                1. Online Stores
                                                                                                                                                                                                2. China Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                        1. Immunomodulators
                                                                                                                                                                                                          1. Immunosuppressants
                                                                                                                                                                                                            1. Interferons
                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                              2. Middle East and Africa Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                                  1. Injectables
                                                                                                                                                                                                                    1. Intramuscular
                                                                                                                                                                                                                      1. Subcutaneous
                                                                                                                                                                                                                        1. Intravenous
                                                                                                                                                                                                                        2. Infusions
                                                                                                                                                                                                                        3. Middle East and Africa Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                          1. Hospital Pharmacy
                                                                                                                                                                                                                            1. Retail Pharmacy
                                                                                                                                                                                                                              1. Online Stores
                                                                                                                                                                                                                              2. Middle East and Africa Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                                                                                            1. Immunosuppressants
                                                                                                                                                                                                                                              1. Interferons
                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                2. UAE Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                                                  1. Oral
                                                                                                                                                                                                                                                    1. Injectables
                                                                                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                                                                                        1. Subcutaneous
                                                                                                                                                                                                                                                          1. Intravenous
                                                                                                                                                                                                                                                          2. Infusions
                                                                                                                                                                                                                                                          3. UAE Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                                                            1. Hospital Pharmacy
                                                                                                                                                                                                                                                              1. Retail Pharmacy
                                                                                                                                                                                                                                                                1. Online Stores
                                                                                                                                                                                                                                                                2. UAE Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                                                                                        1. Immunomodulators
                                                                                                                                                                                                                                                                          1. Immunosuppressants
                                                                                                                                                                                                                                                                            1. Interferons
                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                              2. LATAM Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                                                                                                  1. Injectables
                                                                                                                                                                                                                                                                                    1. Intramuscular
                                                                                                                                                                                                                                                                                      1. Subcutaneous
                                                                                                                                                                                                                                                                                        1. Intravenous
                                                                                                                                                                                                                                                                                        2. Infusions
                                                                                                                                                                                                                                                                                        3. LATAM Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                                                                                          1. Hospital Pharmacy
                                                                                                                                                                                                                                                                                            1. Retail Pharmacy
                                                                                                                                                                                                                                                                                              1. Online Stores
                                                                                                                                                                                                                                                                                              2. LATAM Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                                                                                1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                                                                                  1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                                                                                    1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                                                                                      1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Multiple Sclerosis Drugs Market, By Drug Class
                                                                                                                                                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                                                                                                                                                            1. Immunosuppressants
                                                                                                                                                                                                                                                                                                              1. Interferons
                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                2. Brazil Multiple Sclerosis Drugs Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                  1. Oral
                                                                                                                                                                                                                                                                                                                    1. Injectables
                                                                                                                                                                                                                                                                                                                      1. Intramuscular
                                                                                                                                                                                                                                                                                                                        1. Subcutaneous
                                                                                                                                                                                                                                                                                                                          1. Intravenous
                                                                                                                                                                                                                                                                                                                          2. Infusions
                                                                                                                                                                                                                                                                                                                          3. Brazil Multiple Sclerosis Drugs Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                            1. Hospital Pharmacy
                                                                                                                                                                                                                                                                                                                              1. Retail Pharmacy
                                                                                                                                                                                                                                                                                                                                1. Online Stores
                                                                                                                                                                                                                                                                                                                                2. Brazil Multiple Sclerosis Drugs Market, By Disease Type
                                                                                                                                                                                                                                                                                                                                  1. Relapsing-remitting MS (RRMS)
                                                                                                                                                                                                                                                                                                                                    1. Primary-progressive MS (PPMS)
                                                                                                                                                                                                                                                                                                                                      1. Secondary-progressive MS (SPMS)
                                                                                                                                                                                                                                                                                                                                        1. Progressive-relapsing MS (PRMS)
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                  Related Reports

                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global multiple sclerosis market size was valued at USD 26.37 billion in 2023. It is estimated to reach USD 32.93 billion by 2032, growing at a CAGR of 2.5% during the forecast period (2024–2032). The growing prevalence of multiple scl
                                                                                                                                                                                                                                                                                                                                  Buy Now

                                                                                                                                                                                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                  © Copyright . All rights Reserved.